Singapore: Holmusk, a global behavioural health data analytics company, has raised US$45m in a series B financing round led by Veradigm (formerly Allscripts Healthcare Solutions), with participation from current investors including Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital), and Northwell Holdings, the venture investment arm of Northwell Health, as well as other previous investors….
Home Healthcare Markets International Business Funding round-up: Vésale Bioscience, ArthroSave, NextPoint Therapeutics, Doctor Anywhere, Holmusk